FDA and industry hold public meeting on the issue of drug names and drug errors.
FDA Approves Losartan Potassium for Reduction in Risk of Stroke
The new approval is an oral suspension for patients with hypertension and left ventricular hypertrophy and for the treatment of diabetic nephropathy.
What Does the Future of Pain Medicine Look Like?
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Social Determinants Crucial in Obesity Prevention, Treatment
On both an individual and societal level, researchers explored how social, cultural, and ethnic determinants impact the treatment and management of obesity.
Dispensing Leadership: Defining Your Philosophy
Join Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, for the first episode of Dispensing Leadership, a new podcast from Drug Topics® and RPhAlly.
Food insecurity Linked With Increased Cardiovascular Disease Risk
Because of their accessibility in the community, pharmacists can help to deliver balanced and individualized services and address social determinants of health.
Over Half of Patients With Long COVID Experienced Symptoms for 2 Years
The most commonly reported symptoms of long COVID include neurological, muscular, respiratory, and psychological.
